Details of the Drug Formulaction

General Information of Drug Formulation (ID: F04447)

• Formulation Name: Clarithromycin 250 mg tablet
• Company: Teva Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Clarithromycin	(DM4M1SG)	Acute maxillary sinusitis		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Allura red AC dye	(E00338)	33258	Colorant
Carmellose sodium	(E00625)	Not Available	Disintegrant
FD&C blue no. 2	(E00446)	2723854	Colorant
Hydrazine yellow	(E00409)	164825	Colorant
Magnesium hydroxide	(E00374)	73981	Adsorbent; Buffering agent
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 400	(E00653)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Vanillin	(E00049)	1183	Flavoring agent
Vinylpyrrolidone	(E00668)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent